SCN9A and erythromelalgia: Erythromelalgia is characterized by the combination of recurrent burning pain, warmth and redness of the extremities, and the mutations in SCN9A shift the voltage-dependence of Nav1.7 activation in a hyperpolarized direction, increase ramp currents and slow deactivation.